View in EDS HTML Full Text PDF Full Text

Clinical resistance associated with a novel MAP2K1 mutation in a patient with Langerhans cell histiocytosis.

Saved in:
Bibliographic Details
Title: Clinical resistance associated with a novel MAP2K1 mutation in a patient with Langerhans cell histiocytosis.
Authors: Azorsa DO; Institute of Molecular Medicine, Phoenix Children's Hospital, Phoenix, Arizona.; Department of Child Health, University of Arizona College of Medicine, Phoenix, Arizona., Lee DW; Institute of Molecular Medicine, Phoenix Children's Hospital, Phoenix, Arizona.; Department of Child Health, University of Arizona College of Medicine, Phoenix, Arizona., Wai DH; Institute of Molecular Medicine, Phoenix Children's Hospital, Phoenix, Arizona.; Department of Child Health, University of Arizona College of Medicine, Phoenix, Arizona., Bista R; Institute of Molecular Medicine, Phoenix Children's Hospital, Phoenix, Arizona.; Department of Child Health, University of Arizona College of Medicine, Phoenix, Arizona.; Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, Arizona., Patel AR; Institute of Molecular Medicine, Phoenix Children's Hospital, Phoenix, Arizona.; Department of Child Health, University of Arizona College of Medicine, Phoenix, Arizona.; Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, Arizona., Aleem E; Institute of Molecular Medicine, Phoenix Children's Hospital, Phoenix, Arizona.; Department of Child Health, University of Arizona College of Medicine, Phoenix, Arizona.; Faculty of Science, Alexandria University, Alexandria, Egypt., Henry MM; Department of Child Health, University of Arizona College of Medicine, Phoenix, Arizona.; Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, Arizona., Arceci RJ; Institute of Molecular Medicine, Phoenix Children's Hospital, Phoenix, Arizona.; Department of Child Health, University of Arizona College of Medicine, Phoenix, Arizona.; Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, Arizona.
Source: Pediatric blood & cancer [Pediatr Blood Cancer] 2018 Sep; Vol. 65 (9), pp. e27237. Date of Electronic Publication: 2018 May 16.
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: John Wiley Country of Publication: United States NLM ID: 101186624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1545-5017 (Electronic) Linking ISSN: 15455009 NLM ISO Abbreviation: Pediatr Blood Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 29768711
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Clinical resistance associated with a novel MAP2K1 mutation in a patient with Langerhans cell histiocytosis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Azorsa+DO%22">Azorsa DO</searchLink>; Institute of Molecular Medicine, Phoenix Children's Hospital, Phoenix, Arizona.; Department of Child Health, University of Arizona College of Medicine, Phoenix, Arizona.<br /><searchLink fieldCode="AU" term="%22Lee+DW%22">Lee DW</searchLink>; Institute of Molecular Medicine, Phoenix Children's Hospital, Phoenix, Arizona.; Department of Child Health, University of Arizona College of Medicine, Phoenix, Arizona.<br /><searchLink fieldCode="AU" term="%22Wai+DH%22">Wai DH</searchLink>; Institute of Molecular Medicine, Phoenix Children's Hospital, Phoenix, Arizona.; Department of Child Health, University of Arizona College of Medicine, Phoenix, Arizona.<br /><searchLink fieldCode="AU" term="%22Bista+R%22">Bista R</searchLink>; Institute of Molecular Medicine, Phoenix Children's Hospital, Phoenix, Arizona.; Department of Child Health, University of Arizona College of Medicine, Phoenix, Arizona.; Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, Arizona.<br /><searchLink fieldCode="AU" term="%22Patel+AR%22">Patel AR</searchLink>; Institute of Molecular Medicine, Phoenix Children's Hospital, Phoenix, Arizona.; Department of Child Health, University of Arizona College of Medicine, Phoenix, Arizona.; Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, Arizona.<br /><searchLink fieldCode="AU" term="%22Aleem+E%22">Aleem E</searchLink>; Institute of Molecular Medicine, Phoenix Children's Hospital, Phoenix, Arizona.; Department of Child Health, University of Arizona College of Medicine, Phoenix, Arizona.; Faculty of Science, Alexandria University, Alexandria, Egypt.<br /><searchLink fieldCode="AU" term="%22Henry+MM%22">Henry MM</searchLink>; Department of Child Health, University of Arizona College of Medicine, Phoenix, Arizona.; Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, Arizona.<br /><searchLink fieldCode="AU" term="%22Arceci+RJ%22">Arceci RJ</searchLink>; Institute of Molecular Medicine, Phoenix Children's Hospital, Phoenix, Arizona.; Department of Child Health, University of Arizona College of Medicine, Phoenix, Arizona.; Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, Arizona.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101186624%22">Pediatric blood & cancer</searchLink> [Pediatr Blood Cancer] 2018 Sep; Vol. 65 (9), pp. e27237. <i>Date of Electronic Publication: </i>2018 May 16.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22John+Wiley%22">John Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101186624 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1545-5017 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215455009%22">15455009 </searchLink><i>NLM ISO Abbreviation: </i>Pediatr Blood Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=29768711
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/pbc.27237
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e27237
    Titles:
      – TitleFull: Clinical resistance associated with a novel MAP2K1 mutation in a patient with Langerhans cell histiocytosis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Azorsa DO
      – PersonEntity:
          Name:
            NameFull: Lee DW
      – PersonEntity:
          Name:
            NameFull: Wai DH
      – PersonEntity:
          Name:
            NameFull: Bista R
      – PersonEntity:
          Name:
            NameFull: Patel AR
      – PersonEntity:
          Name:
            NameFull: Aleem E
      – PersonEntity:
          Name:
            NameFull: Henry MM
      – PersonEntity:
          Name:
            NameFull: Arceci RJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2018 Sep
              Type: published
              Y: 2018
          Identifiers:
            – Type: issn-electronic
              Value: 1545-5017
          Numbering:
            – Type: volume
              Value: 65
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: Pediatric blood & cancer
              Type: main
ResultId 1